Home Speaker Nancy Pelosi speaks at a Fed Up? Rise Up! rally exterior the US Capitol in Washington, DC September 24, 2019.Mandel Ngan | AFP | Getty
Home Speaker Nancy Pelosi speaks at a Fed Up? Rise Up! rally exterior the US Capitol in Washington, DC September 24, 2019.
Mandel Ngan | AFP | Getty Photographs
The Home Power and Commerce Committee on Thursday accepted Speaker Nancy Pelosi‘s sweeping drug pricing invoice, a key step in getting the laws to the total Home flooring for a vote later this yr.
The invoice handed on a vote of 30 to 22 on Thursday night.
The principle thrust of Pelosi’s invoice will permit Medicare to barter decrease costs on as many as 250 of the costliest medicine per yr and apply these reductions to non-public well being plans throughout the U.S. The invoice additionally features a penalty on drugmakers that refuse to barter or fail to achieve an settlement with the U.S. authorities, beginning at 65% of the product sales of the drug in query.
Republican members on the committee expressed issues with the laws, significantly that it might discourage innovation for brand new medicines within the pharmaceutical trade. Some GOP members stated the laws was rushed and useless on arrival within the Senate.
“I do not imagine that I used to be elected to put in writing payments that might by no means go wherever,” stated Michael Burgess of Texas, the highest Republican on the Power and Commerce Committee’s well being panel. “And that is precisely the place this invoice is headed.”
Previous to the vote Thursday, Power and Commerce Chairman Frank…